All News #Library
Others
Padagis Appoints Pamela Hoffman As Chief Executive Officer
01 Apr 2026 //
PR NEWSWIRE
Padagis Announces The Launch Of Brinzolamide Ophthalmic Suspension
13 Oct 2023 //
PR NEWSWIRE
Padagis Announces The First Launch Of An Over-The-Counter Naloxone Nasal Spray
08 Aug 2023 //
PR NEWSWIRE
Padagis Announces Acquisition Of 17,000 Square Meter Facility In Yerucham
20 Jul 2023 //
PR NEWSWIRE
Alcon Sues Padagis to Block Copies of Simbrinza Eye Drops (1)
01 Nov 2022 //
BLOOMBERGLAW
Moberg Pharma and Padagis sign agreement for MOB-015 in Israel
04 Aug 2022 //
PRNEWSWIRE
Letter to Pharmacists concerning red dye #40
02 Aug 2022 //
PRESS RELEASE
Padagis Announces 3 Major Product Launches
21 Jun 2022 //
FDA
Padagis Announces the FDA Approval and Launch of an AB Rated Generic Version of Tobradex® Ophthalmic Suspension
21 Mar 2022 //
PRESS RELEASE
Padagis Announces The First-to-Market Launch Of An AB Rated Generic Zomig
16 Nov 2021 //
PRNEWSWIRE
Padagis Launches AB Rated Generic Version Of Zomig Nasal Spray
16 Nov 2021 //
PRNEWSWIRE
Sol-Gel Announces Sale of Generic Dermatology to Partner Padagis for $21 M
04 Nov 2021 //
YAHOO
Sol-Gel Technologies Reports Third Quarter 2021 Financial Results
04 Nov 2021 //
GLOBENEWSWIRE
Sol-Gel to Partner Padagis for $21M
04 Nov 2021 //
GLOBENEWSWIRE
Padagis Announces The FDA Approval And Launch Of An AB Rated GenericOf Doxil®
21 Oct 2021 //
PRNEWSWIRE
Padagis Starts Life Post-Perrigo With Eucrisa Challenge
12 Oct 2021 //
PHARMAINTELLIGENCE
VYNE THERAPEUTICS Management`s Discussion and Analysis of Financial Condition
11 Oct 2021 //
MARKETSCREENER
Padagis Confirms First-to-File Patent Challenge For Generic Version Of Eucrisa®
28 Sep 2021 //
PRNEWSWIRE
Law firm trio directs GE’s bet on surgical tech company BK Medical
24 Sep 2021 //
REUTERS
Patent Filings Roundup: PTAB Denies Lash Company PGR over ITC Investigation
19 Aug 2021 //
IPWATCHDOG
VYNE Therapeutics Reports Second Quarter 2021 Financial Results
12 Aug 2021 //
GLOBENEWSWIRE
Altaris Capital Partners’ $1.55 Billion Acquisition of Padagis
10 Jul 2021 //
GLOBALLEGALCHRONICLE
Perrigo Closes $1.5B Sale of Generic Prescription Drugs Business
06 Jul 2021 //
POWDERBULKSOLIDS

Market Place
Sourcing Support